Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of ... The study was backed by the Aufzien ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

“We are encouraged by these initial Phase 2 safety and immunogenicity data on our ACI-7104.056 active immunotherapy being studied in early Parkinson’s disease. The level of immunogenicity after only 3 ...

2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Researchers Develop Analytical Pipeline to Identify ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...